{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:30:13Z","timestamp":1779114613118,"version":"3.51.4"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T00:00:00Z","timestamp":1508716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T00:00:00Z","timestamp":1508716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Subunit viral vaccines are typically not as efficient as live attenuated or inactivated vaccines at inducing protective immune responses. This paper describes an alternative \u2018biomimetic\u2019 technology; whereby viral antigens were formulated around a polymeric shell in a rationally arranged fashion with a surface glycoprotein coated on to the surface and non-structural antigen and adjuvant encapsulated. We evaluated this model using BVDV E2 and NS3 proteins formulated in poly-(D, L-lactic-co-glycolic acid) (PLGA) nanoparticles adjuvanted with polyinosinic:polycytidylic acid (poly(I:C) as an adjuvant (Vaccine-NP). This Vaccine-NP was compared to ovalbumin and poly(I:C) formulated in a similar manner (Control-NP) and a commercial adjuvanted inactivated BVDV vaccine (IAV), all inoculated subcutaneously and boosted prior to BVDV-1 challenge. Significant virus-neutralizing activity, and E2 and NS3 specific antibodies were observed in both Vaccine-NP and IAV groups following the booster immunisation. IFN-\u03b3 responses were observed in <jats:italic>ex vivo<\/jats:italic> PBMC stimulated with E2 and NS3 proteins in both vaccinated groups. We observed that the protection afforded by the particulate vaccine was comparable to the licenced IAV formulation. In conclusion, the biomimetic particulates showed a promising immunogenicity and efficacy profile that may be improved by virtue of being a customisable mode of delivery.<\/jats:p>","DOI":"10.1038\/s41598-017-13915-x","type":"journal-article","created":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T09:16:24Z","timestamp":1508231784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Design and evaluation of the immunogenicity and efficacy of a biomimetic particulate formulation of viral antigens"],"prefix":"10.1038","volume":"7","author":[{"given":"Victor","family":"Riitho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam A.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5361-4610","authenticated-orcid":false,"given":"Satyanarayana","family":"Somavarapu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Lamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Till","family":"R\u00fcmenapf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Krey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix A.","family":"Rey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1323-3316","authenticated-orcid":false,"given":"Ernesto","family":"Oviedo-Orta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham R.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Locker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falko","family":"Steinbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon P.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,23]]},"reference":[{"key":"13915_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.7774\/cevr.2013.2.2.97","volume":"2","author":"Y Choi","year":"2013","unstructured":"Choi, Y. & Chang, J. Viral vectors for vaccine applications. Clinical and Experimental Vaccine Research \n                           2, 97\u2013105 (2013).","journal-title":"Clinical and Experimental Vaccine Research"},{"key":"13915_CR2","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S0966-842X(03)00208-7","volume":"11","author":"R Noad","year":"2003","unstructured":"Noad, R. & Roy, P. Virus-like particles as immunogens. Trends in Microbiology \n                           11, 438\u2013444 (2003).","journal-title":"Trends in Microbiology"},{"key":"13915_CR3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1365-2567.2006.02552.x","volume":"121","author":"A Reyes-Sandoval","year":"2007","unstructured":"Reyes-Sandoval, A., Harty, J. T. & Todryk, S. M. Viral vector vaccines make memory T cells against malaria. Immunology \n                           121, 158\u2013165 (2007).","journal-title":"Immunology"},{"key":"13915_CR4","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1128\/CVI.00487-09","volume":"17","author":"HR Hghihghi","year":"2010","unstructured":"Hghihghi, H. R. et al. Characterization of host responses against a recombinant fowlpox virus-vectored vaccine expressing the hemagglutinin antigen of an avian influenza virus. Clinical and vaccine immunology: CVI \n                           17, 454\u201363 (2010).","journal-title":"Clinical and vaccine immunology: CVI"},{"key":"13915_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ymeth.2006.07.018","volume":"40","author":"EVL Grgacic","year":"2006","unstructured":"Grgacic, E. V. L. & Anderson, D. A. Virus-like particles: Passport to immune recognition. Methods \n                           40, 60\u201365 (2006).","journal-title":"Methods"},{"key":"13915_CR6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/CJI.0b013e31802cf3e3","volume":"30","author":"P Elamanchili","year":"2007","unstructured":"Elamanchili, P., Lutsiak, C. M., Hamdy, S., Diwan, M. & Samuel, J. \u201cPathogen-mimicking\u201d nanoparticles for vaccine delivery to dendritic cells. Journal of immunotherapy \n                           30, 378\u201395 (2007).","journal-title":"Journal of immunotherapy"},{"key":"13915_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.biomaterials.2016.03.039","volume":"97","author":"AL Siefert","year":"2016","unstructured":"Siefert, A. L., Caplan, M. J. & Fahmy, T. M. Artificial bacterial biomimetic nanoparticles synergize pathogen-associated molecular patterns for vaccine efficacy. Biomaterials \n                           97, 85\u201396 (2016).","journal-title":"Biomaterials"},{"key":"13915_CR8","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jconrel.2011.07.029","volume":"157","author":"A Bershteyn","year":"2012","unstructured":"Bershteyn, A. et al. Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine. J Control Release \n                           157, 354\u201365 (2012).","journal-title":"J Control Release"},{"key":"13915_CR9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1365-2567.2005.02268.x","volume":"117","author":"H Shen","year":"2006","unstructured":"Shen, H. et al. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles. Immunology \n                           117, 78\u201388 (2006).","journal-title":"Immunology"},{"key":"13915_CR10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.molcel.2006.05.012","volume":"22","author":"E Meylan","year":"2006","unstructured":"Meylan, E. & Tschopp, J. Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses. Mol Cell \n                           22, 561\u20139 (2006).","journal-title":"Mol Cell"},{"key":"13915_CR11","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1016\/j.vaccine.2010.08.002","volume":"29","author":"F Steinhagen","year":"2011","unstructured":"Steinhagen, F., Kinjo, T., Bode, C. & Klinman, D. M. TLR-based immune adjuvants. Vaccine \n                           29, 3341\u201355 (2011).","journal-title":"Vaccine"},{"key":"13915_CR12","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature09737","volume":"470","author":"SP Kasturi","year":"2011","unstructured":"Kasturi, S. P. et al. Programming the magnitude and persistence of antibody responses with innate immunity. Nature \n                           470, 543\u20137 (2011).","journal-title":"Nature"},{"key":"13915_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0168-3659(02)00275-4","volume":"85","author":"M Diwan","year":"2002","unstructured":"Diwan, M., Tafaghodi, M. & Samuel, J. Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres. J Control Release \n                           85, 247\u201362 (2002).","journal-title":"J Control Release"},{"key":"13915_CR14","doi-asserted-by":"publisher","first-page":"268","DOI":"10.2174\/1567201811310030003","volume":"10","author":"DJ Kirby","year":"2013","unstructured":"Kirby, D. J. et al. Developing solid particulate vaccine adjuvants: surface bound antigen favours a humoural response, whereas entrapped antigen shows a tendency for cell mediated immunity. Current drug delivery \n                           10, 268\u201378 (2013).","journal-title":"Current drug delivery"},{"key":"13915_CR15","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1586\/erv.10.89","volume":"9","author":"MO Oyewumi","year":"2010","unstructured":"Oyewumi, M. O., Kumar, A. & Cui, Z. Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses. Expert review of vaccines \n                           9, 1095\u2013107 (2010).","journal-title":"Expert review of vaccines"},{"key":"13915_CR16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/32588","volume":"392","author":"J Banchereau","year":"1998","unstructured":"Banchereau, J. & Steinman, R. M. Dendritic cells and the control of immunity. Nature \n                           392, 245\u201352 (1998).","journal-title":"Nature"},{"key":"13915_CR17","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.addr.2007.05.017","volume":"60","author":"LJ Peek","year":"2008","unstructured":"Peek, L. J., Middaugh, C. R. & Berkland, C. Nanotechnology in vaccine delivery. Adv Drug Deliv Rev \n                           60, 915\u201328 (2008).","journal-title":"Adv Drug Deliv Rev"},{"key":"13915_CR18","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ymeth.2006.05.023","volume":"40","author":"JP Scheerlinck","year":"2006","unstructured":"Scheerlinck, J. P. & Greenwood, D. L. Particulate delivery systems for animal vaccines. Methods \n                           40, 118\u201324 (2006).","journal-title":"Methods"},{"key":"13915_CR19","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1073\/pnas.0804897106","volume":"106","author":"FA Sharp","year":"2009","unstructured":"Sharp, F. A. et al. Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proceedings of the National Academy of Sciences of the United States of America \n                           106, 870\u20135 (2009).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"13915_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0378-1135(98)00262-4","volume":"64","author":"H Houe","year":"1999","unstructured":"Houe, H. Epidemiological features and economical importance of bovine virus diarrhoea virus (BVDV) infections. Vet Microbiol \n                           64, 89\u2013107 (1999).","journal-title":"Vet Microbiol"},{"key":"13915_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.biologicals.2012.07.003","volume":"41","author":"JF Ridpath","year":"2013","unstructured":"Ridpath, J. F. Immunology of BVDV vaccines. Biologicals: journal of the International Association of Biological Standardization \n                           41, 14\u20139 (2013).","journal-title":"Biologicals: journal of the International Association of Biological Standardization"},{"key":"13915_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0378-1135(98)00268-5","volume":"64","author":"JT van Oirschot","year":"1999","unstructured":"van Oirschot, J. T., Bruschke, C. J. & van Rijn, P. A. Vaccination of cattle against bovine viral diarrhoea. Vet Microbiol \n                           64, 169\u201383 (1999).","journal-title":"Vet Microbiol"},{"key":"13915_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12917-014-0245-0","volume":"10","author":"CR Bell","year":"2014","unstructured":"Bell, C. R., Kerr, M. G., Scott, P. R., Morrison, W. I. & Brown, H. Evidence of a high incidence of subclinically affected calves in a herd of cattle with fatal cases of Bovine Neonatal Pancytopenia (BNP). BMC veterinary research \n                           10, 245 (2014).","journal-title":"BMC veterinary research"},{"key":"13915_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1297-9716-42-97","volume":"42","author":"F Deutskens","year":"2011","unstructured":"Deutskens, F. et al. Vaccine-induced antibodies linked to bovine neonatal pancytopenia (BNP) recognize cattle major histocompatibility complex class I (MHC I). Veterinary research \n                           42, 97 (2011).","journal-title":"Veterinary research"},{"key":"13915_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S1045-1056(03)00027-7","volume":"31","author":"JJ Endsley","year":"2003","unstructured":"Endsley, J. J., Roth, J. A., Ridpath, J. & Neill, J. Maternal antibody blocks humoral but not T cell responses to BVDV. Biologicals \n                           31, 123\u20135 (2003).","journal-title":"Biologicals"},{"key":"13915_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0168-1702(00)00131-3","volume":"67","author":"T Collen","year":"2000","unstructured":"Collen, T. & Morrison, W. I. CD4(+) T-cell responses to bovine viral diarrhoea virus in cattle. Virus Res \n                           67, 67\u201380 (2000).","journal-title":"Virus Res"},{"key":"13915_CR27","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1099\/vir.0.83251-0","volume":"89","author":"R Liang","year":"2008","unstructured":"Liang, R. et al. DNA prime protein boost strategies protect cattle from bovine viral diarrhea virus type 2 challenge. The Journal of general virology \n                           89, 453\u201366 (2008).","journal-title":"The Journal of general virology"},{"key":"13915_CR28","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1128\/CVI.00565-12","volume":"20","author":"S van Drunen Littel-van den Hurk","year":"2013","unstructured":"van Drunen Littel-van den Hurk, S. et al. Two doses of bovine viral diarrhea virus DNA vaccine delivered by electroporation induce long-term protective immune responses. Clinical and vaccine immunology: CVI \n                           20, 166\u201373 (2013).","journal-title":"Clinical and vaccine immunology: CVI"},{"issue":"Pt 1","key":"13915_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1099\/0022-1317-69-1-77","volume":"69","author":"RO Donis","year":"1988","unstructured":"Donis, R. O., Corapi, W. & Dubovi, E. J. Neutralizing monoclonal antibodies to bovine viral diarrhoea virus bind to the 56K to 58K glycoprotein. The Journal of general virology \n                           69(Pt 1), 77\u201386 (1988).","journal-title":"The Journal of general virology"},{"key":"13915_CR30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1006\/viro.2000.0523","volume":"276","author":"T Collen","year":"2000","unstructured":"Collen, T., Douglas, A. J., Paton, D. J., Zhang, G. & Morrison, W. I. Single amino acid differences are sufficient for CD4(+) T-cell recognition of a heterologous virus by cattle persistently infected with bovine viral diarrhea virus. Virology \n                           276, 70\u201382 (2000).","journal-title":"Virology"},{"key":"13915_CR31","unstructured":"Brownlie, J., Collins, M., Thomas, C. & Thompson, I. Protection of an animal against pestivirus infection. United States patent (2010)."},{"key":"13915_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124689","volume":"10","author":"R Strong","year":"2015","unstructured":"Strong, R. et al. Viral Dose and Immunosuppression Modulate the Progression of Acute BVDV-1 Infection in Calves: Evidence of Long Term Persistence after Intra-Nasal Infection. PloS one \n                           10, e0124689 (2015).","journal-title":"PloS one"},{"key":"13915_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001685","volume":"11","author":"SCTP Rts","year":"2014","unstructured":"Rts, S. C. T. P. Efficacy and safety of the RTS,S\/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites. PLoS medicine \n                           11, e1001685 (2014).","journal-title":"PLoS medicine"},{"key":"13915_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142035","volume":"10","author":"F Khan","year":"2015","unstructured":"Khan, F. et al. Head-to-Head Comparison of Soluble vs. Qbeta VLP Circumsporozoite Protein Vaccines Reveals Selective Enhancement of NANP Repeat Responses. PloS one \n                           10, e0142035 (2015).","journal-title":"PloS one"},{"key":"13915_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/srep19234","volume":"6","author":"KD Brune","year":"2016","unstructured":"Brune, K. D. et al. Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization. Scientific reports \n                           6, 19234 (2016).","journal-title":"Scientific reports"},{"key":"13915_CR36","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1016\/j.vaccine.2015.06.017","volume":"33","author":"RE-A LM","year":"2015","unstructured":"LM, R. E.-A., Thomas, C., Luke, J. J. A. W. & Brownlie, J. Enhanced neutralising antibody response to bovine viral diarrhoea virus (BVDV) induced by DNA vaccination in calves. Vaccine \n                           33, 4004\u201312 (2015).","journal-title":"Vaccine"},{"key":"13915_CR37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.biologicals.2012.07.003","volume":"41","author":"JF Ridpath","year":"2013","unstructured":"Ridpath, J. F. Immunology of BVDV vaccines. Biologicals \n                           41, 14\u201319 (2013).","journal-title":"Biologicals"},{"key":"13915_CR38","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0165-2427(02)00088-0","volume":"87","author":"T Collen","year":"2002","unstructured":"Collen, T., Carr, V., Parsons, K., Charleston, B. & Morrison, W. I. Analysis of the repertoire of cattle CD4(+) T cells reactive with bovine viral diarrhoea virus. Vet Immunol Immunopathol \n                           87, 235\u20138 (2002).","journal-title":"Vet Immunol Immunopathol"},{"key":"13915_CR39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0165-2427(02)00088-0","volume":"87","author":"T Collen","year":"2002","unstructured":"Collen, T., Carr, V., Parsons, K., Charleston, B. & Morrison, W. I. Analysis of the repertoire of cattle CD4+ T cells reactive with bovine viral diarrhoea virus. Veterinary Immunology and Immunopathology \n                           87, 235\u2013238 (2002).","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"13915_CR40","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1016\/j.vaccine.2009.02.010","volume":"27","author":"C Thomas","year":"2009","unstructured":"Thomas, C., Young, N. J., Heaney, J., Collins, M. E. & Brownlie, J. Evaluation of efficacy of mammalian and baculovirus expressed E2 subunit vaccine candidates to bovine viral diarrhoea virus. Vaccine \n                           27, 2387\u20132393 (2009).","journal-title":"Vaccine"},{"key":"13915_CR41","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1128\/AAC.39.11.2574","volume":"39","author":"JP Wong","year":"1995","unstructured":"Wong, J. P., Saravolac, E. G., Sabuda, D., Levy, H. B. & Kende, M. Prophylactic and therapeutic efficacies of poly(IC.LC) against respiratory influenza A virus infection in mice. Antimicrobial agents and chemotherapy \n                           39, 2574\u20136 (1995).","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"13915_CR42","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1073\/pnas.0711976105","volume":"105","author":"C Trumpfheller","year":"2008","unstructured":"Trumpfheller, C. et al. The microbial mimic poly IC induces durable and protective CD4\u2009+\u2009T cell immunity together with a dendritic cell targeted vaccine. Proceedings of the National Academy of Sciences of the United States of America \n                           105, 2574\u20139 (2008).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"13915_CR43","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.cimid.2007.06.006","volume":"31","author":"SR Lee","year":"2008","unstructured":"Lee, S. R., Pharr, G. T., Boyd, B. L. & Pinchuk, L. M. Bovine viral diarrhea viruses modulate toll-like receptors, cytokines and co-stimulatory molecules genes expression in bovine peripheral blood monocytes. Comparative immunology, microbiology and infectious diseases \n                           31, 403\u201318 (2008).","journal-title":"Comparative immunology, microbiology and infectious diseases"},{"key":"13915_CR44","doi-asserted-by":"publisher","first-page":"6588","DOI":"10.1016\/j.vaccine.2015.10.093","volume":"33","author":"AA Walters","year":"2015","unstructured":"Walters, A. A. et al. Assessment of the enhancement of PLGA nanoparticle uptake by dendritic cells through the addition of natural receptor ligands and monoclonal antibody. Vaccine \n                           33, 6588\u201395 (2015).","journal-title":"Vaccine"},{"key":"13915_CR45","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4110\/in.2011.11.3.163","volume":"11","author":"YR Lee","year":"2011","unstructured":"Lee, Y. R., Lee, Y. H., Im, S. A., Kim, K. & Lee, C. K. Formulation and Characterization of Antigen-loaded PLGA Nanoparticles for Efficient Cross-priming of the Antigen. Immune network \n                           11, 163\u20138 (2011).","journal-title":"Immune network"},{"key":"13915_CR46","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1016\/j.biomaterials.2012.03.041","volume":"33","author":"SL Demento","year":"2012","unstructured":"Demento, S. L. et al. Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype. Biomaterials \n                           33, 4957\u201364 (2012).","journal-title":"Biomaterials"},{"key":"13915_CR47","unstructured":"Brownlie, J., Collins, M., Thomas, C. & Thompson, I. (Google Patents, 2010)."},{"key":"13915_CR48","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1631\/jzus.2007.B0153","volume":"8","author":"ZI Rajput","year":"2007","unstructured":"Rajput, Z. I., Hu, S. H., Xiao, C. W. & Arijo, A. G. Adjuvant effects of saponins on animal immune responses. Journal of Zhejiang University. Science. B \n                           8, 153\u201361 (2007).","journal-title":"Journal of Zhejiang University. Science. B"},{"key":"13915_CR49","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/ni1223","volume":"6","author":"G Napolitani","year":"2005","unstructured":"Napolitani, G., Rinaldi, A., Bertoni, F., Sallusto, F. & Lanzavecchia, A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol \n                           6, 769\u201376 (2005).","journal-title":"Nat Immunol"},{"key":"13915_CR50","unstructured":"Zhu, D. & Tuo, W. QS-21: A Potent Vaccine Adjuvant. Natural products chemistry & research \n                           3 (2016)."},{"key":"13915_CR51","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0378-5173(02)00342-3","volume":"245","author":"RS Raghuvanshi","year":"2002","unstructured":"Raghuvanshi, R. S. et al. Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants. International journal of pharmaceutics \n                           245, 109\u201321 (2002).","journal-title":"International journal of pharmaceutics"},{"key":"13915_CR52","doi-asserted-by":"crossref","unstructured":"Garg, R., Latimer, L., Gerdts, V., Potter, A. & van Drunen Littel-van den Hurk, S. Intranasal immunization with a single dose of the fusion protein formulated with a combination adjuvant induces long-term protective immunity against respiratory syncytial virus. Human vaccines & immunotherapeutics, 0 (2017).","DOI":"10.1080\/21645515.2017.1349584"},{"key":"13915_CR53","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.vetimm.2017.07.003","volume":"190","author":"S Subramaniam","year":"2017","unstructured":"Subramaniam, S. et al. Dendritic cell-targeted porcine reproductive and respiratory syndrome virus (PRRSV) antigens adjuvanted with polyinosinic-polycytidylic acid (poly (I:C)) induced non-protective immune responses against heterologous type 2 PRRSV challenge in pigs. Veterinary immunology and immunopathology \n                           190, 18\u201325 (2017).","journal-title":"Veterinary immunology and immunopathology"},{"key":"13915_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12917-015-0481-y","volume":"11","author":"F Mansoor","year":"2015","unstructured":"Mansoor, F. et al. Comparing the immune response to a novel intranasal nanoparticle PLGA vaccine and a commercial BPI3V vaccine in dairy calves. BMC veterinary research \n                           11, 220 (2015).","journal-title":"BMC veterinary research"},{"key":"13915_CR55","doi-asserted-by":"publisher","first-page":"5603","DOI":"10.2147\/IJN.S72318","volume":"9","author":"L Pan","year":"2014","unstructured":"Pan, L. et al. Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles. International journal of nanomedicine \n                           9, 5603\u201318 (2014).","journal-title":"International journal of nanomedicine"},{"key":"13915_CR56","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.rvsc.2013.06.023","volume":"95","author":"OV Kavanagh","year":"2013","unstructured":"Kavanagh, O. V., Adair, B. M., Welsh, M. & Earley, B. Immunogenetic responses in calves to intranasal delivery of bovine respiratory syncytial virus (BRSV) epitopes encapsulated in poly (DL-lactide-co-glycolide) microparticles. Research in veterinary science \n                           95, 786\u201393 (2013).","journal-title":"Research in veterinary science"},{"key":"13915_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027605","volume":"6","author":"G Wang","year":"2011","unstructured":"Wang, G. et al. Intranasal delivery of cationic PLGA nano\/microparticles-loaded FMDV DNA vaccine encoding IL-6 elicited protective immunity against FMDV challenge. PloS one \n                           6, e27605 (2011).","journal-title":"PloS one"},{"key":"13915_CR58","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jconrel.2016.12.039","volume":"247","author":"S Dhakal","year":"2017","unstructured":"Dhakal, S. et al. Biodegradable nanoparticle delivery of inactivated swine influenza virus vaccine provides heterologous cell-mediated immune response in pigs. Journal of controlled release: official journal of the Controlled Release Society \n                           247, 194\u2013205 (2017).","journal-title":"Journal of controlled release: official journal of the Controlled Release Society"},{"key":"13915_CR59","first-page":"1519","volume":"9","author":"B Binjawadagi","year":"2014","unstructured":"Binjawadagi, B. et al. An innovative approach to induce cross-protective immunity against porcine reproductive and respiratory syndrome virus in the lungs of pigs through adjuvanted nanotechnology-based vaccination. International journal of nanomedicine \n                           9, 1519\u201335 (2014).","journal-title":"International journal of nanomedicine"},{"key":"13915_CR60","doi-asserted-by":"crossref","unstructured":"Mokhtar, H. et al. Evaluation of hydrophobic chitosan-based particulate formulations of porcine reproductive and respiratory syndrome virus vaccine candidate T cell antigens. Veterinary microbiology (2017).","DOI":"10.1016\/j.vetmic.2017.01.037"},{"key":"13915_CR61","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/ilar\/ilv009","volume":"56","author":"V Gerdts","year":"2015","unstructured":"Gerdts, V. et al. Large animal models for vaccine development and testing. ILAR journal \n                           56, 53\u201362 (2015).","journal-title":"ILAR journal"},{"key":"13915_CR62","doi-asserted-by":"crossref","first-page":"8606","DOI":"10.1128\/jvi.70.12.8606-8613.1996","volume":"70","author":"G Meyers","year":"1996","unstructured":"Meyers, G., Tautz, N., Becher, P., Thiel, H. J. & Kummerer, B. M. Recovery of cytopathogenic and noncytopathogenic bovine viral diarrhea viruses from cDNA constructs. Journal of virology \n                           70, 8606\u201313 (1996).","journal-title":"Journal of virology"},{"key":"13915_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000762","volume":"6","author":"T Krey","year":"2010","unstructured":"Krey, T. et al. The disulfide bonds in glycoprotein E2 of hepatitis C virus reveal the tertiary organization of the molecule. PLoS pathogens \n                           6, e1000762 (2010).","journal-title":"PLoS pathogens"},{"key":"13915_CR64","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1016\/j.vaccine.2012.02.029","volume":"30","author":"SP Graham","year":"2012","unstructured":"Graham, S. P. et al. Characterisation of vaccine-induced, broadly cross-reactive IFN-gamma secreting T cell responses that correlate with rapid protection against classical swine fever virus. Vaccine \n                           30, 2742\u20138 (2012).","journal-title":"Vaccine"},{"key":"13915_CR65","doi-asserted-by":"publisher","DOI":"10.1136\/vr.132.9.227","volume":"132","author":"RC Hibberd","year":"1993","unstructured":"Hibberd, R. C., Turkington, A. & Brownlie, J. Fatal bovine viral diarrhoea virus infection of adult cattle. Vet Rec \n                           132, 227 (1993).","journal-title":"Vet Rec"},{"key":"13915_CR66","unstructured":"Finney, D. J. (Charles Griffin & Co., London and High Wycombe, 1978)."},{"key":"13915_CR67","doi-asserted-by":"crossref","unstructured":"Meyling, A. in Recent Advances in Virus Diagnosis (ed J.B. MacFerran M.S. McNulty) 37\u201346 (Martinus Nijhoff, 1984).","DOI":"10.1007\/978-94-009-6039-8_4"},{"key":"13915_CR68","unstructured":"Clarke, M. C., Brownlie, J. & Howard, C. J. In Pestivirus Infections of Ruminants (ed J. W. Harkness) 3-10 (CEC, 1987)."},{"key":"13915_CR69","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0166-0934(99)00010-5","volume":"79","author":"A McGoldrick","year":"1999","unstructured":"McGoldrick, A., Bensaude, E., Ibata, G., Sharp, G. & Paton, D. J. Closed one-tube reverse transcription nested polymerase chain reaction for the detection of pestiviral RNA with fluorescent probes. Journal of virological methods \n                           79, 85\u201395 (1999).","journal-title":"Journal of virological methods"},{"key":"13915_CR70","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jviromet.2009.06.005","volume":"161","author":"SA La Rocca","year":"2009","unstructured":"La Rocca, S. A. & Sandvik, T. A short target real-time RT-PCR assay for detection of pestiviruses infecting cattle. Journal of virological methods \n                           161, 122\u20137 (2009).","journal-title":"Journal of virological methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13915-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13915-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13915-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T12:19:40Z","timestamp":1671797980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13915-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,23]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["13915"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-13915-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,23]]},"assertion":[{"value":"14 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13743"}}